Based on SEC filing data. A biotech company founded in 2015 and based in Wilmington, Delaware raised $3.0 million in seed-stage equity funding. The company is in the early stages of development.
Get notified the moment Gladius Pharmaceuticals Corp files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.